Pharma

Your Article Summary

See Latest Articles

Alnylam and Medtronic Present New Late-Stage Pre-Clinical Data on ALN-HTT, an RNAi Therapeutic for the Treatment of Huntingtons Disease
Medtronic, 09/16/09

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and Medtronic, Inc., announced the presentation of new pre–clinical research findings from their Huntington's disease program at the 2009 World Congress on Huntington's Disease held September 2009 in Vancouver, British Columbia. Together, the two companies are developing a drug–device combination for the treatment of Huntington's disease.

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

Quality of trials reported as conference abstracts in China: How well are they reported
International Journal of Technology Assessment in Health Care, 11/05/09

User Groups Prove Helpful
HealthDataManagement, 11/03/09

Salix Pharmaceuticals Reviews American Association For The Study Of Liver Diseases Annual Meeting
Salix Pharmaceuticals, 11/03/09

See All of Conferences/Meetings

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09

FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 10/30/09

Gyrus PlasmaKinetic bipolar coagulation device for liver resection
Australian and New Zealand Journal of Surgery, 11/13/09

See All of Medical Devices/Products